Atai Life Stock Today

ATAI
 Stock
  

USD 3.68  0.06  1.66%   

Market Performance
0 of 100
Odds Of Distress
Over 52
Atai Life is trading at 3.68 as of the 29th of June 2022. This is a 1.66% increase since the beginning of the trading day. The stock's open price was 3.62. Atai Life has 52 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Atai Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of July 2020 and ending today, the 29th of June 2022. Click here to learn more.
Fiscal Year End
December
IPO Date
18th of June 2021
Category
Healthcare
ISIN
NL0015000DX5
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 160.3 M outstanding shares of which 3.25 M shares are presently shorted by private and institutional investors with about 3.98 trading days to cover. More on Atai Life Sciences

Moving together with Atai Life

0.84BBIBrickell Biotech TrendingPairCorr
0.67BCRXBiocryst Pharma Upward RallyPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Atai Life Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Atai Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Atai Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Atai Life Sciences generated a negative expected return over the last 90 days
Atai Life Sciences has high historical volatility and very poor performance
Atai Life Sciences has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 20.38 M. Net Loss for the year was (167.81 M) with profit before overhead, payroll, taxes, and interest of 20.38 M.
Atai Life Sciences currently holds about 362.27 M in cash with (63.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.25.
Atai Life Sciences has a frail financial position based on the latest SEC disclosures
Latest headline from www.labiotech.eu: The top psychedelic drug developers leading the market - Labiotech.eu
New SymbolAACG
CEO, DirectorChengYaw Sun
Fama & French Classification
Average Analyst Recommendation
Analysts covering Atai Life report their recommendations after researching Atai Life's financial statements, talking to executives and customers, or listening in on Atai Life's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Atai Life Sciences. The Atai Life consensus assessment is calculated by taking the average forecast from all of the analysts covering Atai Life.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Atai Life Sciences based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Atai Life Sciences financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 2 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares134.1 M138.3 M
Sufficiently Down
Increasing
Slightly volatile
Weighted Average Shares Diluted134.1 M138.3 M
Sufficiently Down
Increasing
Slightly volatile
Total Assets331.4 M414.2 M
Significantly Down
Increasing
Slightly volatile
Total Liabilities23.9 M28.2 M
Fairly Down
Increasing
Slightly volatile
Current Assets296.6 M375.1 M
Significantly Down
Increasing
Slightly volatile
Current Liabilities17.7 M20.9 M
Fairly Down
Increasing
Slightly volatile
Total Debt984.9 K743 K
Significantly Up
Increasing
Slightly volatile
Gross Margin0.890.9
Fairly Down
Decreasing
Slightly volatile
Asset Turnover0.04740.0477
Slightly Down
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Atai Life's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldUndervalued
Financial Strength
Atai Life's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Atai Life's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Atai Life's financial leverage. It provides some insight into what part of Atai Life's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Atai Life's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Atai Life deploys its capital and how much of that capital is borrowed.
Liquidity
Atai Life cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 743 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Atai Life Sciences has a current ratio of 17.56, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Atai Life until it has trouble settling it off, either with new capital or with free cash flow. So, Atai Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Atai Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Atai Life to invest in growth at high rates of return. When we think about Atai Life's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(64.91 Million)Share
Atai Life Sciences (ATAI) is traded on NASDAQ Exchange in USA. It is located in Krausenstrasse 9-10 and employs 87 people. Atai Life is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 586.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Atai Life's market, we take the total number of its shares issued and multiply it by Atai Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Atai Life Sciences conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 160.3 M outstanding shares of which 3.25 M shares are presently shorted by private and institutional investors with about 3.98 trading days to cover. Atai Life Sciences currently holds about 362.27 M in cash with (63.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.25.
Check Atai Life Probability Of Bankruptcy
Ownership
Atai Life holds a total of one hundred sixty million three hundred thousand outstanding shares. Atai Life Sciences shows 9.41 percent if its outstanding shares held by insiders and 9.41 percent owned by other corporate entities . Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Atai Life Ownership Details

Atai Life Stock Price Odds Analysis

What are Atai Life's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Atai Life jumping above the current price in 90 days from now is about 75.63%. The Atai Life Sciences probability density function shows the probability of Atai Life stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.981. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Atai Life will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Atai Life Sciences is significantly underperforming DOW.
  Odds Below 3.68HorizonTargetOdds Above 3.68
24.29%90 days
 3.68 
75.63%
Based on a normal probability distribution, the odds of Atai Life to move above the current price in 90 days from now is about 75.63 (This Atai Life Sciences probability density function shows the probability of Atai Life Stock to fall within a particular range of prices over 90 days) .

Atai Life Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Atai Life that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Atai Life's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Atai Life's value.
InstituionSecurity TypeTotal SharesValue
Alpha Wave Global LpCommon Shares2.1 M10.9 M
Morgan StanleyCommon Shares1.8 M9.1 M
Group One Trading LpPut Options694.1 K3.5 M
View Atai Life Diagnostics

Atai Life Historical Income Statement

Atai Life Sciences Income Statement is one of the three primary financial statements used for reporting Atai Life's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Atai Life Sciences revenue and expense. Atai Life Income Statement primarily focuses on the company's revenues and expenses during a particular period.
View More Fundamentals

Atai Life Stock Against Markets

Picking the right benchmark for Atai Life stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Atai Life stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Atai Life is critical whether you are bullish or bearish towards Atai Life Sciences at a given time.

Similar Equity Warning - ATAI

Atai Life Sciences was forked

The entity Atai Life Sciences with a symbol ATAI was recently forked. You can potentially use ATA Creativity Global with a symbol AACG from now on.

Atai Life Corporate Directors

Atai Life corporate directors refer to members of an Atai Life board of directors. The board of directors generally takes responsibility for the Atai Life's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Atai Life's board members must vote for the resolution. The Atai Life board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Yiu Tsui - Independent DirectorProfile
Andrew Yan - Independent DirectorProfile
Lin Wang - Co-Founder, Consultant and DirectorProfile
Hope Ni - Independent DirectorProfile

Investing Atai Life Sciences

You need to understand the risk of investing before taking a position in Atai Life. The danger of trading Atai Life Sciences is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Atai Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Atai Life. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Atai Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Atai Life Sciences information on this page should be used as a complementary analysis to other Atai Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Atai Life Stock analysis

When running Atai Life Sciences price analysis, check to measure Atai Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atai Life is operating at the current time. Most of Atai Life's value examination focuses on studying past and present price action to predict the probability of Atai Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atai Life's price. Additionally, you may evaluate how the addition of Atai Life to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Is Atai Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atai Life. If investors know Atai Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atai Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.97
Market Capitalization
581.9 M
Return On Assets
-0.38
Return On Equity
-0.91
The market value of Atai Life Sciences is measured differently than its book value, which is the value of Atai Life that is recorded on the company's balance sheet. Investors also form their own opinion of Atai Life's value that differs from its market value or its book value, called intrinsic value, which is Atai Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atai Life's market value can be influenced by many factors that don't directly affect Atai Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atai Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Atai Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atai Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.